Prevalence of Sickle Cell Trait and Rare Hemoglobin Variants in the Metropolitan Washington DC Area

J Hematol. 2020 Sep;9(3):93-95. doi: 10.14740/jh603. Epub 2020 Aug 14.

Xiaomei Niu¹, Christian S Parry², Angela Mason¹, Barbara Harrison^{1

3}, Seyed Mehdi Nouraie⁴, Tatiana Ammosova^{1

5}, Juan Salomon-Andonie¹, Patricia A Oneal^{1

6}, Victor R Gordeuk⁷, James G Taylor^{1

5}, Sergei Nekhai^{1

2

5}

¹ Center for Sickle Cell Disease, Howard University, Washington, DC 20059, USA.
² Department of Microbiology, Howard University, Washington, DC 20059, USA.
³ Department of Genetics and Human Genetics, Howard University, Washington, DC 20059, USA.
⁴ Department of Medicine and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
⁵ Department of Medicine, Howard University, Washington, DC 20059, USA.
⁶ Food and Drug Administration, Silver Spring, MD 20993, USA.
⁷ Section of Hematology-Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.

No abstract available

Grants and funding